for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-FDA Says Authorizes Booster Dose Of Pfizer-Biontech Covid-19 Vaccine For Certain Populations

Sept 22 (Reuters) - FDA:

* FDA SAYS AUTHORIZES BOOSTER DOSE OF PFIZER-BIONTECH COVID-19 VACCINE FOR CERTAIN POPULATIONS

* FDA SAYS AUTHORIZES BOOSTER DOSE OF PFIZER-BIONTECH COVID-19 VACCINE FOR INDIVIDUALS 65 YEARS OF AGE AND OLDER

* FDA SAYS AUTHORIZES BOOSTER DOSE OF PFIZER-BIONTECH COVID-19 VACCINE FOR INDIVIDUALS 18 THROUGH 64 YEARS OF AGE AT HIGH RISK OF SEVERE COVID-19

* FDA SAYS AUTHORIZES BOOSTER DOSE OF PFIZER-BIONTECH COVID-19 VACCINE FOR INDIVIDUALS 18 THROUGH 64 YEARS OF AGE THAT PUTS THEM AT HIGH RISK

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up